173 related articles for article (PubMed ID: 29491387)
1. Understanding the Structure, Multimerization, Subcellular Localization and mC Selectivity of a Genomic Mutator and Anti-HIV Factor APOBEC3H.
Ito F; Yang H; Xiao X; Li SX; Wolfe A; Zirkle B; Arutiunian V; Chen XS
Sci Rep; 2018 Feb; 8(1):3763. PubMed ID: 29491387
[TBL] [Abstract][Full Text] [Related]
2. Flexibility in Nucleic Acid Binding Is Central to APOBEC3H Antiviral Activity.
Bohn JA; DaSilva J; Kharytonchyk S; Mercedes M; Vosters J; Telesnitsky A; Hatziioannou T; Smith JL
J Virol; 2019 Dec; 93(24):. PubMed ID: 31578294
[TBL] [Abstract][Full Text] [Related]
3. The Role of RNA in HIV-1 Vif-Mediated Degradation of APOBEC3H.
Wang J; Becker JT; Shi K; Lauer KV; Salamango DJ; Aihara H; Shaban NM; Harris RS
J Mol Biol; 2019 Dec; 431(24):5019-5031. PubMed ID: 31628948
[TBL] [Abstract][Full Text] [Related]
4. Sequence and structural determinants of human APOBEC3H deaminase and anti-HIV-1 activities.
Mitra M; Singer D; Mano Y; Hritz J; Nam G; Gorelick RJ; Byeon IJ; Gronenborn AM; Iwatani Y; Levin JG
Retrovirology; 2015 Jan; 12():3. PubMed ID: 25614027
[TBL] [Abstract][Full Text] [Related]
5. Biochemical Characterization of APOBEC3H Variants: Implications for Their HIV-1 Restriction Activity and mC Modification.
Gu J; Chen Q; Xiao X; Ito F; Wolfe A; Chen XS
J Mol Biol; 2016 Nov; 428(23):4626-4638. PubMed ID: 27534815
[TBL] [Abstract][Full Text] [Related]
6. Reduced APOBEC3H variant anti-viral activities are associated with altered RNA binding activities.
Zhen A; Du J; Zhou X; Xiong Y; Yu XF
PLoS One; 2012; 7(7):e38771. PubMed ID: 22859935
[TBL] [Abstract][Full Text] [Related]
7. The Structural Interface between HIV-1 Vif and Human APOBEC3H.
Ooms M; Letko M; Simon V
J Virol; 2017 Mar; 91(5):. PubMed ID: 28031368
[TBL] [Abstract][Full Text] [Related]
8. The localization of APOBEC3H variants in HIV-1 virions determines their antiviral activity.
Ooms M; Majdak S; Seibert CW; Harari A; Simon V
J Virol; 2010 Aug; 84(16):7961-9. PubMed ID: 20519396
[TBL] [Abstract][Full Text] [Related]
9. RNA-Mediated Dimerization of the Human Deoxycytidine Deaminase APOBEC3H Influences Enzyme Activity and Interaction with Nucleic Acids.
Feng Y; Wong L; Morse M; Rouzina I; Williams MC; Chelico L
J Mol Biol; 2018 Dec; 430(24):4891-4907. PubMed ID: 30414963
[TBL] [Abstract][Full Text] [Related]
10. Mapping Region of Human Restriction Factor APOBEC3H Critical for Interaction with HIV-1 Vif.
Nakashima M; Tsuzuki S; Awazu H; Hamano A; Okada A; Ode H; Maejima M; Hachiya A; Yokomaku Y; Watanabe N; Akari H; Iwatani Y
J Mol Biol; 2017 Apr; 429(8):1262-1276. PubMed ID: 28336404
[TBL] [Abstract][Full Text] [Related]
11. The resistance of human APOBEC3H to HIV-1 NL4-3 molecular clone is determined by a single amino acid in Vif.
Ooms M; Letko M; Binka M; Simon V
PLoS One; 2013; 8(2):e57744. PubMed ID: 23469063
[TBL] [Abstract][Full Text] [Related]
12. The Antiviral and Cancer Genomic DNA Deaminase APOBEC3H Is Regulated by an RNA-Mediated Dimerization Mechanism.
Shaban NM; Shi K; Lauer KV; Carpenter MA; Richards CM; Salamango D; Wang J; Lopresti MW; Banerjee S; Levin-Klein R; Brown WL; Aihara H; Harris RS
Mol Cell; 2018 Jan; 69(1):75-86.e9. PubMed ID: 29290613
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 competition experiments in humanized mice show that APOBEC3H imposes selective pressure and promotes virus adaptation.
Nakano Y; Misawa N; Juarez-Fernandez G; Moriwaki M; Nakaoka S; Funo T; Yamada E; Soper A; Yoshikawa R; Ebrahimi D; Tachiki Y; Iwami S; Harris RS; Koyanagi Y; Sato K
PLoS Pathog; 2017 May; 13(5):e1006348. PubMed ID: 28475648
[TBL] [Abstract][Full Text] [Related]
14. Recurrent Loss of APOBEC3H Activity during Primate Evolution.
Garcia EI; Emerman M
J Virol; 2018 Sep; 92(17):. PubMed ID: 29925657
[TBL] [Abstract][Full Text] [Related]
15. The DNA cytosine deaminase APOBEC3H haplotype I likely contributes to breast and lung cancer mutagenesis.
Starrett GJ; Luengas EM; McCann JL; Ebrahimi D; Temiz NA; Love RP; Feng Y; Adolph MB; Chelico L; Law EK; Carpenter MA; Harris RS
Nat Commun; 2016 Sep; 7():12918. PubMed ID: 27650891
[TBL] [Abstract][Full Text] [Related]
16. Structural basis of chimpanzee APOBEC3H dimerization stabilized by double-stranded RNA.
Matsuoka T; Nagae T; Ode H; Awazu H; Kurosawa T; Hamano A; Matsuoka K; Hachiya A; Imahashi M; Yokomaku Y; Watanabe N; Iwatani Y
Nucleic Acids Res; 2018 Nov; 46(19):10368-10379. PubMed ID: 30060196
[TBL] [Abstract][Full Text] [Related]
17. Analysis of human APOBEC3H haplotypes and anti-human immunodeficiency virus type 1 activity.
Wang X; Abudu A; Son S; Dang Y; Venta PJ; Zheng YH
J Virol; 2011 Apr; 85(7):3142-52. PubMed ID: 21270145
[TBL] [Abstract][Full Text] [Related]
18. Polymorphism in human APOBEC3H affects a phenotype dominant for subcellular localization and antiviral activity.
Li MM; Emerman M
J Virol; 2011 Aug; 85(16):8197-207. PubMed ID: 21653666
[TBL] [Abstract][Full Text] [Related]
19. Natural Polymorphisms and Oligomerization of Human APOBEC3H Contribute to Single-stranded DNA Scanning Ability.
Feng Y; Love RP; Ara A; Baig TT; Adolph MB; Chelico L
J Biol Chem; 2015 Nov; 290(45):27188-27203. PubMed ID: 26396192
[TBL] [Abstract][Full Text] [Related]
20. APOBEC3H polymorphisms associated with the susceptibility to HIV-1 infection and AIDS progression in Japanese.
Sakurai D; Iwatani Y; Ohtani H; Naruse TK; Terunuma H; Sugiura W; Kimura A
Immunogenetics; 2015 Apr; 67(4):253-7. PubMed ID: 25721876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
